TriLink has been an industry leader in synthesizing high quality oligonucleotides for research, diagnostics, therapeutics, and OEM for more than 20 years. We offer a wide selection of DNA, …

TriLink BioTechnologies, part of Maravai LifeSciences, is a best-in-class contract development and manufacturing organization (CDMO) for the synthesis of nucleic acids, NTPs and mRNA …

Biotin-16-7-Deaza-7-Propargylamino-2'-deoxyguanosine-5'-Triphosphate

Leverage a legacy of trailblazing innovation in your mRNA research and discovery with TriLink. Our dedicated staff has specialized mRNA expertise to support your journey, helping you …

TriLink offers a robust portfolio of patented CleanCap ® cap analogs for use in the discovery or GMP manufacturing of vaccines, cell therapies, gene replacement therapies, and more, …

Please keep me informed about updates from TriLink Biotechnologies, including webinars, new product releases, and upcoming events. Please note the minimum starting synthesis scale we …

TriLink has delivered more than 10,000 discovery mRNA constructs across diverse applications to our clients. Our team has been leading the way in IVT mRNA synthesis since 2012.

Explore TriLink’s high-quality mRNA products, including reporter, Cas9, antigen, and gene replacement. Ready-to-use or customizable to your needs.

CleanCap® Reagent AG is TriLink's patented co-transcriptional capping reagent for in vitro transcription of 5' capped mRNA resulting in a Cap 1 structure. CleanCap has shown to …

TriLink has a legacy of trailblazing innovation in mRNA synthesis. Now, with the mRNAbuilder® tool, you can leverage our up-leveled sequence design platform and order your construct online.